Navigation Links
Kuros Completes Patient Recruitment in its European Clinical Study With KUR-023, its Novel Dural Sealant Product Candidate
Date:8/16/2011

Officer of Kuros, commented: "Kuros is pleased to have completed recruitment of this study and is especially pleased to have achieved this ahead of schedule.  KUR-023 is the first product based on our synthetic technology to have entered into clinical studies and we look forward to reporting the results of this study in the near future."

 

About Dural Sealants

The brain and spinal cord are surrounded by a membrane called the dura mater. This membrane forms part of the blood-brain barrier and acts to contain the cerebrospinal fluid within the brain and spinal cord. During most cranial and some spinal surgeries the integrity of the dura mater is breached either intentionally by incision or unintentionally. Water-tight closure of any incision or tear in the dura mater is of clinical importance, since CSF leakage can result in complications such as delayed wound healing, compression of neurological tissues and infection (potentially causing meningitis).

Dural Sealants are applied as an adjunct to the normal dural closure procedure, which is most commonly sutures.

About Kuros

http://www.kuros.ch

Kuros is a biotechnology company that is focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, spine and wound indications.

Kuros has two biomaterial technology platforms, one based on fibrin sealants and the other based on a synthetic technology that can mimic fibrin in many of its attributes.  These materials can be used alone or in combination with biologically active molecules.

The synthetic technology is tailorable and allows generation of products that are delivered as liquids or gels but polymerise, in or on living tissues, to form materials with different physical properties.  For example, Kuros' synthetic technology can be utilized to develop products ranging from an elastic and deg
'/>"/>

SOURCE Kuros Biosurgery AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kuros Announces Allowance of US Patent for the Local Application of Parathyroid Hormone (PTH) for Bone Healing
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
8. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
9. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014 Research and Markets ... Chinese Aseptic Packaging Industry Report 2014" report to ... The Global and Chinese Aseptic Packaging Industry ... current state of the global Aseptic Packaging industry with ... provides a basic overview of the industry including definitions, ...
(Date:7/30/2014)... N.J. , July 30, 2014  InnoPharma, Inc. ... Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in ... agitation and disturbed behaviors in patients with schizophrenia or ... this generic injectable drug, InnoPharma has entered into an ... Sandoz Canada will make, use, sell, market and ...
(Date:7/30/2014)... YORK and KISSING, Germany ... and distributor of a single use and computer-assisted ("robotic") ... (Homi) Shamir , a worldwide recognized medical device executive, ... Mr. Shamir is a highly respected global ... recent assignment he served as President and Chief Executive ...
Breaking Medicine Technology:Global and Chinese Aseptic Packaging Industry Report 2014 2InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3
... Okla., March 9, 2011 Sandra Smith filed suit today ... over a failed hip replacement system from Johnson & Johnson, ... market.  John David Hart of the Law Offices of John ... Ms. Smith. Smith, of Yukon, underwent surgeries ...
... Inc. (NYSE: WST ) today announced that management ... Miami, FL.  Management will present an overview of West,s business ... ET. A live audio webcast of the Company,s ... will be accessible from the Company,s website at www.westpharma.com/en/investors ...
Cached Medicine Technology:Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device 2
(Date:7/30/2014)... that could help doctors decide which bladder cancer patients ... effective, according to a study* published in the ... from The University of Manchester, funded by the Medical ... high levels of a protein, called ,HIF-1α, were more ... with carbon dioxide gas and nicotinamide tablets at ...
(Date:7/30/2014)... CA (July 30, 2014) With the advent of ... a popular science and researchers must work to ... study of stroke rehabilitation. A new study out ... systematic shift in perspective and suggests that chronically ... strongly promote stroke motor recovery, for example by ...
(Date:7/30/2014)... percent of Parkinson,s disease (PD) patients and their ... challenge: the occurrence of impulse control disorders (ICDs) ... spending. Yet the presence of PD in these ... A team of investigators from the Perelman School ... the Parkinson,s Disease Research, Education and Clinical Center ...
(Date:7/30/2014)... Europe commercial aviation actuation system market is estimated at ... reach $1,686.72 million by 2019 at a CAGR of ... of opportunities and challenges which will assume prominence in ... in the past, yet the sector has regained quickly, ... growth rate of approximately 5 % per year. Despite ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Bringing Disney ... September event hosted by the Central Iowa Chapter of ... Institute is bringing its renowned professional development course, “Disney’s ... 16, 2014. The full-day world class workshop will inspire ... business results, retain employees and satisfy customers. , “Disney ...
Breaking Medicine News(10 mins):Health News:Scientists pinpoint bladder cancer patients who could benefit from 'tumor-softening' treatment 2Health News:Neuro researchers advocate for a shift in thinking for stroke rehabilitation 2Health News:Penn researchers: Naltrexone may diminish impulse control disorders in Parkinson's disease patients 2Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 4Health News:Central Iowa Chapter of ATD Hosts Exclusive Disney Institute for Central Iowa Businesses 2Health News:Central Iowa Chapter of ATD Hosts Exclusive Disney Institute for Central Iowa Businesses 3
... CHICAGO, June 17 Continuing its efforts to educate, inform, ... not-for-profit patient-focused organization, is hosting its 25-minute live call-in show, ... June 22, 2009 at 6:00 PM on Channel 21. ... discussion with Deborah Harper Brown, Clinical Pharmacist, who will inform ...
... Registration is underway for the CPAP SUCCESS GROUP being held at ... Monday, July 6 at 4PM at 541 Main Street in the ... designed to help struggling CPAP users become better accustomed to CPAP ... and effectively by learning simple relaxation techniques that promote breathing normally ...
... release of the IntelliFlowRx workflow management system provides ... , ENGLEWOOD, Colo., June 17 Baxa Corporation ... workflow management system. IntelliFlowRx is designed to ... preparation. The system also streamlines compliance with ...
... gene, variant ups violence inclination, study finds , WEDNESDAY, June 17 ... blamed for boys joining violent street gangs. But a new study ... in part, in their genes. , Boys who have a variant ... the "warrior gene" -- are not only more likely to be ...
... , - SLA Centennial Observance ... Century , Elsevier has been awarded ... BioMedicine and the Life Sciences" at the Special Library,Association,s (SLA) ... published by Elsevier, many on behalf of renowned,societies, were also ...
... Recognizes Entrepreneurial Excellence in Health and Life Sciences Category , ... -- Accuray Incorporated (Nasdaq: ARAY ), a ... Euan Thomson, Ph.D., the company,s president and CEO, received the ... the Health and Life Sciences category in Northern California. ...
Cached Medicine News:Health News:The Consumer's Role in Medication Safety -- An Interactive Discussion with a Pharmacist on Live TV 2Health News:Help for Struggling CPAP Users Comes to Sleep HealthCenters in Weymouth 2Health News:Baxa Corporation Releases IntelliFlowRx(TM) Upgrades 2Health News:Boys May Feel a Genetic Pull Toward Gangs 2Health News:Elsevier Honored as "The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences" by the Special Libraries Association 2Health News:Elsevier Honored as "The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences" by the Special Libraries Association 3Health News:Elsevier Honored as "The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences" by the Special Libraries Association 4Health News:Accuray's Euan Thomson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Recipient in Northern California 2Health News:Accuray's Euan Thomson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Recipient in Northern California 3
... quality patient care., ,S/5 Anesthesia Delivery ... anesthesia delivery. As part of the S/5 ... electronically controlled gas delivery and agent vaporization ... create a truly integrated system. The S/5 ...
... filler and Tegagel hydrogel wound filler ... specially formulated to help provide a ... to enhance wound healing. The unique, ... for management of non-draining, minimally draining ...
... SS is a complete physician preference card ... management system for all the supply management ... preference card system combined with a broad ... entire case cart and operating suite supply ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
Medicine Products: